The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site.
Open accessAbstract
A metabolite of estradiol, 2-methoxyestradiol (2ME), inhibits angiogenesis in the chicken embryo chorioallantoic membrane assay. Since 2ME causes mitotic perturbations, we examined its interactions with tubulin. In our standard 1.0 M glutamate system (plus 1.0 mM MgCl2 at 37 degrees C), superstoichiometric concentrations (relative to tubulin) of 2ME inhibited the nucleation and propagation phases of tubulin assembly but did not affect the reaction extent. Although polymer formed in the presence of 2ME was more cold-stable than control polymer, morphology was little changed. Under suboptimal reaction conditions (0.8 M glutamate/no MgCl2 at 26 degrees C), substoichiometric 2ME totally inhibited polymerization. No other estrogenic compound was as effective as 2ME as an inhibitor of polymerization or of the binding of colchicine to tubulin. Inhibition of colchicine binding was competitive (Ki, 22 microM). Thus, a mammalian metabolite of estradiol binds to the colchicine site of tubulin and, depending on reaction conditions, either inhibits assembly or seems to be incorporated into a polymer with altered stability properties.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fotsis, T., Zhang, Y., Pepper, M. S., Adlercreutz, H., Montesano, R., Nawroth, P. P., & Schweigerer, L. (1994) · Nature · doi:10.1038/368237a0 · Cited by 736
A New Class of Steroids Inhibits Angiogenesis in the Presence of Heparin or a Heparin Fragment
Crum, R., Szabo, S., & Folkman, J. (1985) · Science · doi:10.1126/science.2416056 · Cited by 488
Self-citationLin, C. M., Singh, S. B., Chu, P. S., Dempcy, R. O., Schmidt, J. M., Pettit, G. R., & Hamel, E. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09364-2 · Cited by 278
Self-citationHamel, E., & Lin, C. M. (1984) · Biochemistry · doi:10.1021/bi00313a026 · Cited by 226
Self-citationSeegers, J. C., Aveling, M.-L., van Aswegen, C. H., Cross, M. F., Koch, F., & Joubert, W. S. (1989) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(89)90455-x · Cited by 151
Colchicine inhibition of microtubule assembly via copolymer formation.
Sternlicht, H., & Ringel, I. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)86741-8 · Cited by 146
Fltzgerald, T. J. (1976) · Biochemical Pharmacology · doi:10.1016/0006-2952(76)90108-8 · Cited by 145
Berg, D., Sonsalla, R., & Kuss, E. (1983) · European Journal of Endocrinology · doi:10.1530/acta.0.1030282 · Cited by 114
Merriam, G. R., MacLusky, N. J., Picard, M. K., & Naftolin, F. N. (1980) · Steroids · doi:10.1016/0039-128x(80)90062-8 · Cited by 111
Lacey, E., & Watson, T. R. (1985) · Biochemical Pharmacology · doi:10.1016/0006-2952(85)90611-2 · Cited by 84
Cited by
Männistö, P. T., & Kaakkola, S. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01423-6 · Cited by 1,068
“2-Methoxy estradiol also disturbs the function of microtubules (D’Amato et al., 1994; Hamel et al., 1996), and it is one of the most potent endogenous inhibitors of angiogenesis known (Fotsis et al.”
Functional role of estrogen metabolism in target cells: review and perspectives
Zhu, B. (1998) · Carcinogenesis · doi:10.1093/carcin/19.1.1 · Cited by 971
Mechanobiology and diseases of mechanotransduction
Ingber, D. (2003) · Annals of Medicine · doi:10.1080/07853890310016333 · Cited by 843
Superoxide dismutase as a target for the selective killing of cancer cells
Huang, P., Feng, L., Oldham, E. A., Keating, M. J., & Plunkett, W. (2000) · Nature · doi:10.1038/35030140 · Cited by 842
2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF
Mabjeesh, N. J., Escuin, D., LaVallee, T. M., Pribluda, V. S., Swartz, G. M., Johnson, M. S., Willard, M. T., Zhong, H., Simons, J. W., & Giannakakou, P. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00077-1 · Cited by 730
Tubulin as a target for anticancer drugs: Agents which interact with the mitotic spindle
Jordan, A., Hadfield, J. A., Lawrence, N. J., & McGown, A. T. (1998) · Medicinal Research Reviews · doi:10.1002/(sici)1098-1128(199807)18:4<259::aid-med3>3.0.co;2-u · Cited by 673
Endogenous Inhibitors of Angiogenesis
Nyberg, P., Xie, L., & Kalluri, R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2427 · Cited by 553
Drugs that target dynamic microtubules: A new molecular perspective
Stanton, R. A., Gernert, K. M., Nettles, J. H., & Aneja, R. (2011) · Medicinal Research Reviews · doi:10.1002/med.20242 · Cited by 526
Natural Product Hybrids as New Leads for Drug Discovery
Tietze, L. F., Bell, H. P., & Chandrasekhar, S. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200200553 · Cited by 516
(1996) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60862-3 · Cited by 510
Molecular mechanisms of novel therapeutic approaches for multiple myeloma
Hideshima, T., & Anderson, K. C. (2002) · Nature Reviews Cancer · doi:10.1038/nrc952 · Cited by 425
Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia
Kanasaki, K., Palmsten, K., Sugimoto, H., Ahmad, S., Hamano, Y., Xie, L., Parry, S., Augustin, H. G., Gattone, V. H., Folkman, J., et al. (2008) · Nature · doi:10.1038/nature06951 · Cited by 381
Estrogen and Angiogenesis: A Review
Losordo, D. W., & Isner, J. M. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.1.6 · Cited by 352
Indole, a core nucleus for potent inhibitors of tubulin polymerization
Brancale, A., & Silvestri, R. (2007) · Medicinal Research Reviews · doi:10.1002/med.20080 · Cited by 344
Zhou, Y., Hileman, E. O., Plunkett, W., Keating, M. J., & Huang, P. (2003) · Blood · doi:10.1182/blood-2002-08-2512 · Cited by 327
Endogenous angiogenesis inhibitors
FOLKMAN, J. (2004) · APMIS · doi:10.1111/j.1600-0463.2004.apm11207-0809.x · Cited by 321
Self-citationMicrotubule-interfering Agents Stimulate the Transcription of Cyclooxygenase-2
Subbaramaiah, K., Hart, J. C., Norton, L., & Dannenberg, A. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.20.14838 · Cited by 300
2‐Methoxyestradiol, a Promising Anticancer Agent
Lakhani, N. J., Sarkar, M. A., Venitz, J., & Figg, W. D. (2003) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.23.2.165.32088 · Cited by 274
Hamel, E. (2003) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:38:1:1 · Cited by 272
Self-citationAngiogenesis Research: Guidelines for Translation to Clinical Application
Browder, T., Palmblad, J., & Folkman, J. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616197 · Cited by 259
Self-citationLépine, J., Bernard, O., Plante, M., Têtu, B., Pelletier, G., Labrie, F., Bélanger, A., & Guillemette, C. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0331 · Cited by 205
Significant antitumor activity in vivo following treatment with the microtubule agent ENMD-1198
LaVallee, T. M., Burke, P. A., Swartz, G. M., Hamel, E., Agoston, G. E., Shah, J., Suwandi, L., Hanson, A. D., Fogler, W. E., Sidor, C. F., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0107 · Cited by 67
Self-citationDirect modulation of microtubule stability contributes to anthracene general anesthesia
Emerson, D. J., Weiser, B. P., Psonis, J., Liao, Z., Taratula, O., Fiamengo, A., Wang, X., Sugasawa, K., Smith, A. B., Eckenhoff, R. G., et al. (2013) · Journal of the American Chemical Society · doi:10.1021/ja311171u · Cited by 63
Metadata
- Authors
- D'Amato, R. J., Lin, C. M., Flynn, E., Folkman, J., & Hamel, E.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1994-04-26
- Volume
- 91
- Issue
- 9
- Pages
- 3964-3968
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2034426069
- Cited by
- 406
- References
- 17
- FWCI
- 2.01
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.